Lucknow, India: Chandan Healthcare Limited (NSE – CHANDAN), – Chandan Healthcare Limited, one of the leading players in Diagnostic sector having Pan India presence, has announced its unaudited Financial Results for Q1 FY27.

Consolidated Key Financial Highlights:

Q1 FY27 Consolidated Key Financial Highlights (YoY)

  • Total Income of ₹ 82.26 Cr, YoY growth of 19.62%
  • EBITDA of ₹ 20.98 Cr, YoY growth of 42.27%
  • EBITDA Margin of 25.51%, YoY growth of 406 Bps
  • PAT of ₹ 7.50 Cr, YoY growth of 29.51%
  • PAT Margin of 9.11%, YoY growth of 70 Bps
  • EPS of ₹ 2.59, YoY growth of 12.61%

Q1 FY27 Consolidated Key Financial Highlights (QoQ)

  • Total Income of ₹ 82.26 Cr, QoQ growth of 6.24%
  • EBITDA of ₹ 20.98 Cr, QoQ growth of 57.50%
  • EBITDA Margin of 25.51%, QoQ growth of 830 Bps
  • PAT of ₹ 7.50 Cr, QoQ growth of 52.82%
  • PAT Margin of 9.11%, QoQ growth of 278 Bps
  • EPS of ₹ 2.59, QoQ growth of 32.82%

For more details, visit the company’s website: https://chandandiagnostic.com/

Commenting on the financial performance, Mr. Amar Singh, Promoter and Chairman & Managing Director of Chandan Healthcare Limited, said, “We delivered a healthy performance during the quarter, with Total Income of ₹82.26 Cr, reflecting growth of 19.62% YoY. The performance was supported by continued expansion of our diagnostic network, growing contribution from the B2G business and steady progress across our partnership-led growth initiatives.

Our network expansion gained significant momentum during the quarter, with 134 franchise centres added, taking the franchise network to 264 centres. We also added 1 Comprehensive Diagnostic Centre, 2 Diagnostic Centres and 3 standalone Labs, taking our total network to 327 centres, including franchise centres. The franchise rollout continues to progress well, enabling us to expand our reach efficiently across existing and new markets.

We also strengthened our presence in key geographies during the quarter. The acquisition of Nishkam Imaging, an established radiology and pathology centre in New Delhi, further strengthened our Delhi

network, while the launch of our Vadodara centre marked our entry into Gujarat. Our rollout with Jeena Sikho hospitals and clinics is progressing well, and we plan to expand diagnostic services across additional partner facilities.

Going forward, our focus remains on accelerating the franchise rollout, further expanding our franchise footprint, scaling our partnership-led network, growing the B2G business and selectively expanding our presence across attractive markets. We remain focused on building a wider, accessible and integrated diagnostics network through a balanced expansion of franchise and owned centres, while driving sustainable growth.”

Key Q1 FY27 Operational Highlights

Nishkam Imaging Acquisition Adds to Delhi Diagnostic Network

  • Acquired Nishkam Imaging, an established radiology & pathology centre in Yamuna Vihar, New Delhi, strengthening the company’s existing Delhi footprint.
  • Expands diagnostic capabilities through integrated radiology and pathology services, enhancing patient accessibility and service offerings.
  • Leverages an established local patient base and modern infrastructure, supporting deeper penetration in a high-demand urban catchment.

Vadodara Centre Marks Chandan Healthcare’s Entry into Gujarat

  • Entered Gujarat with a new diagnostic centre in Vadodara, broadening the company’s presence into Western India.
  • Offers comprehensive diagnostic services, including blood investigations, TMT, ECG, EEG, PFT, X-Ray and BMD.
  • Partnered with Jeena Sikho hospitals & clinics, enabling diagnostic access for patients across its associated healthcare network.
  • Expansion planned across additional partner facilities, supporting a partnership-led diagnostic network in Gujarat.